Orticumab

Orticumab (INN) is a human monoclonal antibody that is used as an anti-inflammatory agent and binds to oxLDL. It acts as an immunomodulator.[1]

Orticumab
Monoclonal antibody
TypeWhole antibody
SourceHuman
TargetoxLDL
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none

References


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.